Markets
BSE See NSE See 47,705.80
-243.62 (-0.51%)
Query Board

Query Board

Print

This section gives decisive investment rationales to our subscribers on the stock queries they have raised to our research team.  

 

To read the entire article, you must be a DSIJ magazine subscriber.

 
 

 

Comments are only visible to subscribers.

DSIJ Mindshare

Caplin Point subsidiary gets USFDA approval for Milrinone Lactate injection

Ganesh V / Article rating: 4.5

Caplin Point Laboratories Limited announced on Monday after the market hours that its subsidiary company, Caplin Steriles Limited, has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Milrinone Lactate injection. 

1345Last